BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19963059)

  • 1. Phospholipase D2 acts as an important regulator in LPS-induced nitric oxide synthesis in Raw 264.7 cells.
    Park SY; Cho JH; Ma W; Choi HJ; Han JS
    Cell Signal; 2010 Apr; 22(4):619-28. PubMed ID: 19963059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells.
    Park SY; Baik YH; Cho JH; Kim S; Lee KS; Han JS
    Cytokine; 2008 Oct; 44(1):126-34. PubMed ID: 18723372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
    Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
    J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase D1 is required for lipopolysaccharide-induced tumor necrosis factor-α expression and production through S6K1/JNK/c-Jun pathway in Raw 264.7 cells.
    Oh CH; Park SY; Han JS
    Cytokine; 2014 Mar; 66(1):69-77. PubMed ID: 24548427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
    Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells.
    Oh JH; Lee TJ; Park JW; Kwon TK
    Eur J Pharmacol; 2008 Dec; 599(1-3):11-7. PubMed ID: 18838070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway.
    Lin MW; Tsao LT; Chang LC; Chen YL; Huang LJ; Kuo SC; Tzeng CC; Lee MR; Wang JP
    Biochem Pharmacol; 2007 Jun; 73(11):1796-806. PubMed ID: 17379190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shikonin derivatives inhibited LPS-induced NOS in RAW 264.7 cells via downregulation of MAPK/NF-kappaB signaling.
    Cheng YW; Chang CY; Lin KL; Hu CM; Lin CH; Kang JJ
    J Ethnopharmacol; 2008 Nov; 120(2):264-71. PubMed ID: 18835347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-Hydroxyquinoline inhibits iNOS expression and nitric oxide production by down-regulating LPS-induced activity of NF-kappaB and C/EBPbeta in Raw 264.7 cells.
    Kim YH; Woo KJ; Lim JH; Kim S; Lee TJ; Jung EM; Lee JM; Park JW; Kwon TK
    Biochem Biophys Res Commun; 2005 Apr; 329(2):591-7. PubMed ID: 15737626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-kappaB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells.
    Kim JH; Kim DH; Baek SH; Lee HJ; Kim MR; Kwon HJ; Lee CH
    Biochem Pharmacol; 2006 Apr; 71(8):1198-205. PubMed ID: 16457781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosmanol potently inhibits lipopolysaccharide-induced iNOS and COX-2 expression through downregulating MAPK, NF-kappaB, STAT3 and C/EBP signaling pathways.
    Lai CS; Lee JH; Ho CT; Liu CB; Wang JM; Wang YJ; Pan MH
    J Agric Food Chem; 2009 Nov; 57(22):10990-8. PubMed ID: 19856917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene, a selective estrogen receptor modulator, inhibits lipopolysaccharide-induced nitric oxide production by inhibiting the phosphatidylinositol 3-kinase/Akt/nuclear factor-kappa B pathway in RAW264.7 macrophage cells.
    Lee SA; Park SH; Kim BC
    Mol Cells; 2008 Jul; 26(1):48-52. PubMed ID: 18511885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive effect of novel aromatic diamine compound on nuclear factor-kappaB-dependent expression of inducible nitric oxide synthase in macrophages.
    Shin HM; Byung Hak Kim ; Eun Yong Chung ; Jung SH; Yeong Shik Kim ; Kyung Rak Min ; Kim Y
    Eur J Pharmacol; 2005 Oct; 521(1-3):1-8. PubMed ID: 16183054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin inhibits lipopolysaccharide induction of granulocyte-colony stimulating factor and inducible nitric oxide synthase expression in macrophages by reducing the levels of octamer-binding factor-2.
    Chou YY; Gao JI; Chang SF; Chang PY; Lu SC
    FEBS J; 2011 Jan; 278(1):85-96. PubMed ID: 21114628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equol inhibits nitric oxide production and inducible nitric oxide synthase gene expression through down-regulating the activation of Akt.
    Kang JS; Yoon YD; Han MH; Han SB; Lee K; Park SK; Kim HM
    Int Immunopharmacol; 2007 Apr; 7(4):491-9. PubMed ID: 17321472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kappaB pathways.
    Jung WK; Choi I; Lee DY; Yea SS; Choi YH; Kim MM; Park SG; Seo SK; Lee SW; Lee CM; Park YM; Choi IW
    Int J Biochem Cell Biol; 2008; 40(11):2572-82. PubMed ID: 18571461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways.
    Chang YC; Li PC; Chen BC; Chang MS; Wang JL; Chiu WT; Lin CH
    Cell Signal; 2006 Aug; 18(8):1235-43. PubMed ID: 16289764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation.
    Granja AG; Sabina P; Salas ML; Fresno M; Revilla Y
    J Virol; 2006 Nov; 80(21):10487-96. PubMed ID: 17041221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of ivermectin on nitric oxide and prostaglandin E2 production in LPS-stimulated RAW 264.7 macrophages.
    Zhang X; Song Y; Xiong H; Ci X; Li H; Yu L; Zhang L; Deng X
    Int Immunopharmacol; 2009 Mar; 9(3):354-9. PubMed ID: 19168156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucosamine inhibits LPS-induced COX-2 and iNOS expression in mouse macrophage cells (RAW 264.7) by inhibition of p38-MAP kinase and transcription factor NF-kappaB.
    Rafi MM; Yadav PN; Rossi AO
    Mol Nutr Food Res; 2007 May; 51(5):587-93. PubMed ID: 17440993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.